Sailaja Pisipati
Mayo Clinic
Internal medicineOdds ratioRandomized controlled trialAdverse effectPlaceboCorticosteroidMechanical ventilationPneumoperitoneumMEDLINE2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Convalescent plasmaLength of hospitalizationWeb of sciencePharmacotherapyGeneral surgeryText miningMedicineMeta-analysis
Publications 3
#1Sailaja Pisipati (Mayo Clinic)H-Index: 1
#2Viveksandeep Thoguluva Chandrasekar (Mayo Clinic)H-Index: 1
Last. Rahul Pannala (Mayo Clinic)H-Index: 21
view all 5 authors...
#1Yashwitha Sai Pulakurthi (Academy of Medical Sciences, United Kingdom)H-Index: 2
#2John M. PedersonH-Index: 2
Last. Kirk W. EvansonH-Index: 1
view all 26 authors...
BACKGROUND Corticosteroid treatment is an effective and common therapeutic strategy for various inflammatory lung pathologies and may be an effective treatment for coronavirus disease 2019 (COVID-19). The purpose of this systematic review and meta-analysis of current literature was to investigate the clinical outcomes associated with corticosteroid treatment of COVID-19. METHODS We systematically searched PubMed, medRxiv, Web of Science, and Scopus databases through March 10, 2021 to identify ra...
1 CitationsSource
#1Charan Thej Reddy Vegivinti (Manipal University)H-Index: 1
#2John M. PedersonH-Index: 2
Last. Ameer E. HassanH-Index: 1
view all 28 authors...
The purpose of this systematic review and meta-analysis was to examine clinical outcomes associated with convalescent plasma therapy in COVID-19 patients. We performed a literature search on PubMed, medRxiv, Web of Science, and Scopus to identify studies published up to December 10th, 2020 that examined the efficacy of convalescent plasma treatment for COVID-19. The primary endpoints were mortality, clinical improvement, and hospital length of stay. We screened 859 studies that met the search cr...
3 CitationsSource